Motley Fool Wealth Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-412,864
Closed -$5.69M 39
2026
Q1
$5.69M Sell
412,864
-151,972
-27% -$2.29M 0.64% 54
2025
Q4
$10.2M Sell
564,836
-92,647
-14% -$1.66M 0.79% 46
2025
Q3
$12.2M Buy
657,483
+275,184
+72% +$4.32M 0.83% 36
2025
Q2
$6.12M Buy
+382,299
New +$6.82M 0.37% 86

Other funds holding CLBT

Motley Fool Wealth Management's CLBT Position: Q2 2026 in Review

Motley Fool Wealth Management sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 412,864 shares — an estimated $5.69M sold.

Motley Fool Wealth Management first reported a position in CLBT in Q2 2025 and held it in 4 quarters. The position peaked at $12.2M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Motley Fool Wealth Management reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Motley Fool Wealth Management sold 412,864 Cellebrite shares in Q2 2026, an estimated $5.69M.
  • Motley Fool Wealth Management first reported a position in Cellebrite in Q2 2025 and held it in 4 quarters.
  • Motley Fool Wealth Management's Cellebrite position peaked at $12.2M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Motley Fool Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.